 serum lipid abnormalities high-priority patients Normalization serum lipid levels possible patients myocardial cerebrovascular peripheral vascular disease Clinical trials coronary artery disease overall mortality rates lipid-lowering therapy Treatment low-density lipoprotein cholesterol levels mg/dL total triglyceride levels mg/dL high-density lipoprotein cholesterol levels mg/dL men mg/dL women Nonlipid coronary risk factors possible Lipid-lowering therapy dietary modification drug treatment colestipol hydrochloride Colestid cholestyramine Cholybar Questran Mevacor Lopid nicotinic acid Nicolar